{"id":44122,"date":"2022-05-19T15:01:26","date_gmt":"2022-05-19T13:01:26","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/"},"modified":"2022-05-19T15:01:26","modified_gmt":"2022-05-19T13:01:26","slug":"atec-to-participate-in-upcoming-investor-events","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/","title":{"rendered":"ATEC to Participate in Upcoming Investor Events"},"content":{"rendered":"<div>\n<p>CARLSBAD, Calif.&#8211;(BUSINESS WIRE)&#8211;Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that executive management will participate in the following investor events:\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220519005027\/en\/1458648\/4\/informed_logo_on_white.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220519005027\/en\/1458648\/21\/informed_logo_on_white.jpg\"><\/a><\/p>\n<ul class=\"bwlistdisc\">\n<li>\nTodd Koning, Chief Financial Officer, will present at the Wells Fargo Securities West Coast MedTech Tour on June 2, 2022, at 11:30am PDT.\n<\/li>\n<li>\nPat Miles, Chairman and Chief Executive Officer, and Todd Koning will participate in the Goldman Sachs 43<sup>rd<\/sup> Annual Global Healthcare Conference at the Terranea Resort in Rancho Palos Verdes, CA, on June 13, 2022.\n<\/li>\n<\/ul>\n<p>\n<b>About ATEC<\/b>\n<\/p>\n<p>\nATEC, through its wholly owned subsidiaries, Alphatec Spine, Inc., EOS imaging S.A. and SafeOp Surgical, Inc., is a medical device company dedicated to revolutionizing the approach to spine surgery through clinical distinction. ATEC\u2019s Organic Innovation Machine<sup>TM<\/sup> is focused on developing new approaches that integrate seamlessly with the Company\u2019s expanding AlphaInformatiX Platform to better inform surgery and more safely and reproducibly achieve the goals of spine surgery. ATEC\u2019s vision is to become the Standard Bearer in Spine. For more information, visit us at <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.atecspine.com&amp;esheet=52722320&amp;newsitemid=20220519005027&amp;lan=en-US&amp;anchor=www.atecspine.com&amp;index=1&amp;md5=05535d621da96f07f749a1d9424be78c\" rel=\"nofollow noopener\" shape=\"rect\">www.atecspine.com<\/a>.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\n<b>Investor\/Media Contact:<\/b><br \/>Tina Jacobsen, CFA<br \/>\n<br \/>Investor Relations<br \/>\n<br \/>(760) 494-6790<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;a&#x69;l&#x74;o&#x3a;&#105;&#x6e;&#118;&#x65;&#115;t&#x6f;r&#x72;e&#x6c;&#97;&#x74;&#105;&#x6f;&#110;&#x73;&#64;a&#x74;e&#x63;s&#x70;&#105;&#x6e;&#101;&#x2e;&#99;&#x6f;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">i&#110;&#118;&#101;&#x73;&#x74;&#x6f;rr&#101;&#108;&#x61;&#x74;&#x69;&#x6f;ns&#64;&#97;&#x74;&#x65;&#x63;&#x73;p&#105;&#110;&#101;&#x2e;&#x63;&#x6f;m<\/a>\n<\/p>\n<p>\n<b>Company Contact:<\/b><br \/>J. Todd Koning<br \/>\n<br \/>Chief Financial Officer<br \/>\n<br \/>Alphatec Holdings, Inc.<br \/>\n<br \/><a target=\"_blank\" href=\"m&#97;&#105;&#108;&#x74;&#x6f;&#x3a;in&#118;&#101;&#x73;&#x74;&#x6f;&#x72;re&#108;&#97;&#x74;&#x69;&#x6f;&#x6e;s&#64;&#97;&#116;&#x65;&#x63;&#x73;pi&#110;&#101;&#46;&#x63;&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x69;&#x6e;&#x76;&#x65;&#x73;&#x74;&#x6f;&#x72;&#x72;&#x65;&#x6c;&#x61;&#x74;&#x69;&#111;&#110;&#115;&#64;&#97;&#116;&#101;&#99;&#115;&#112;&#105;ne&#46;com<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>CARLSBAD, Calif.&#8211;(BUSINESS WIRE)&#8211;Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that executive management will participate in the following investor events: Todd Koning, Chief Financial Officer, will present at the Wells Fargo Securities West Coast MedTech Tour on June 2, 2022, at &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-44122","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ATEC to Participate in Upcoming Investor Events - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ATEC to Participate in Upcoming Investor Events - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"CARLSBAD, Calif.&#8211;(BUSINESS WIRE)&#8211;Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that executive management will participate in the following investor events: Todd Koning, Chief Financial Officer, will present at the Wells Fargo Securities West Coast MedTech Tour on June 2, 2022, at ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-19T13:01:26+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220519005027\/en\/1458648\/21\/informed_logo_on_white.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-participate-in-upcoming-investor-events\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-participate-in-upcoming-investor-events\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"ATEC to Participate in Upcoming Investor Events\",\"datePublished\":\"2022-05-19T13:01:26+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-participate-in-upcoming-investor-events\\\/\"},\"wordCount\":215,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-participate-in-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220519005027\\\/en\\\/1458648\\\/21\\\/informed_logo_on_white.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-participate-in-upcoming-investor-events\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-participate-in-upcoming-investor-events\\\/\",\"name\":\"ATEC to Participate in Upcoming Investor Events - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-participate-in-upcoming-investor-events\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-participate-in-upcoming-investor-events\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220519005027\\\/en\\\/1458648\\\/21\\\/informed_logo_on_white.jpg\",\"datePublished\":\"2022-05-19T13:01:26+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-participate-in-upcoming-investor-events\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-participate-in-upcoming-investor-events\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-participate-in-upcoming-investor-events\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220519005027\\\/en\\\/1458648\\\/21\\\/informed_logo_on_white.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220519005027\\\/en\\\/1458648\\\/21\\\/informed_logo_on_white.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/atec-to-participate-in-upcoming-investor-events\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ATEC to Participate in Upcoming Investor Events\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ATEC to Participate in Upcoming Investor Events - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/","og_locale":"en_US","og_type":"article","og_title":"ATEC to Participate in Upcoming Investor Events - Pharma Trend","og_description":"CARLSBAD, Calif.&#8211;(BUSINESS WIRE)&#8211;Alphatec Holdings, Inc. (Nasdaq: ATEC), a provider of innovative spine surgery solutions dedicated to revolutionizing the approach to spine surgery, announced today that executive management will participate in the following investor events: Todd Koning, Chief Financial Officer, will present at the Wells Fargo Securities West Coast MedTech Tour on June 2, 2022, at ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-19T13:01:26+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220519005027\/en\/1458648\/21\/informed_logo_on_white.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"ATEC to Participate in Upcoming Investor Events","datePublished":"2022-05-19T13:01:26+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/"},"wordCount":215,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220519005027\/en\/1458648\/21\/informed_logo_on_white.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/","url":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/","name":"ATEC to Participate in Upcoming Investor Events - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220519005027\/en\/1458648\/21\/informed_logo_on_white.jpg","datePublished":"2022-05-19T13:01:26+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220519005027\/en\/1458648\/21\/informed_logo_on_white.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220519005027\/en\/1458648\/21\/informed_logo_on_white.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/atec-to-participate-in-upcoming-investor-events\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"ATEC to Participate in Upcoming Investor Events"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44122","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=44122"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/44122\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=44122"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=44122"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=44122"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}